Study Suggests Semaglutide May Reduce Opioid Overdose Risk in Patients with Type 2 Diabetes
A new JAMA study indicates that semaglutide produced up to a 68% lower risk of opioid overdose for patients with type 2 diabetes compared to other antidiabetic medications.